How PI3K and AKT inhibitors are changing breast cancer treatment. | Francisco J. Esteva, MD, PhD posted on the topic | LinkedIn

Breast Cancer Breakthroughs Episode 16: On the Horizon of PI3K Pathway Inhibition

I didn’t fight cancer. I’m starving it, disrupting it, and rewiring the terrain it depends on through science, intuition, and unwavering faith. When I was told cancer had returned, I knew I had to approach healing differently this time not from fear, but from understanding. So I began using a metabolic and integrative approach, one that looks at the body as an ecosystem, not a battlefield. Strategically, I started incorporating: 💊 Metformin — lowers glucose and cuts off one of cancer’s favorite

The Cancer Genome Atlas (TCGA)